Evaluating Scarring Alopecia Therapies from the Patient Perspective: Knowledge, Barriers to Care, and Treatment Satisfaction

The study surveyed 294 adults with scarring alopecia to understand their experiences with treatment, highlighting significant barriers such as limited access to knowledgeable providers and lack of awareness about therapies. Despite these challenges, patients who received treatment generally reported satisfaction. The study found that only 37.5% had well-controlled symptoms, and 78.9% experienced depression or anxiety related to their condition. Awareness of Janus kinase inhibitors was high (71%), but usage was low (30%) due to provider reluctance, insurance issues, and costs. The research emphasizes the need for better provider education, broader insurance coverage, and patient assistance programs to improve access to care and address the psychosocial distress associated with scarring alopecia.